Prospective evaluation of the conversion rate of HER2, ER and PR between primary tumors and corresponding metastases. CONVERTHER/GEICAM 2009-03 study

dc.contributor.author	Antolín Novoa, Silvia
dc.date.accessioned	2017-06-07T07:07:04Z
dc.date.available	2017-06-07T07:07:04Z
dc.date.issued	2011
dc.identifier.issn	0008-5472
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2797
dc.language.iso	eng
dc.title	Prospective evaluation of the conversion rate of HER2, ER and PR between primary tumors and corresponding metastases. CONVERTHER/GEICAM 2009-03 study
dc.type	Publicación de congreso
dc.authorsophos	De Duenas Martinez, E.
dc.authorsophos	Lluch, A.
dc.authorsophos	Guerrero, A.
dc.authorsophos	Chacon, J. I.
dc.authorsophos	Perez, R.
dc.authorsophos	Antolin, S.
dc.authorsophos	Blancas, I.
dc.authorsophos	Ferrer-Lozano, J.
dc.authorsophos	Burgues, O.
dc.authorsophos	Lopez, A.
dc.authorsophos	Gonzalez-Angulo, A. M.
dc.identifier.doi	10.1158/0008-5472.SABCS11-P2-12-17
dc.identifier.sophos	9072
dc.issue.number	24 Suppl
dc.journal.title	CANCER RESEARCH
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	71

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.